Robbins LLP is Investigating Allegations that Phreesia, Inc. (PHR) Misled Investors Regarding the Sustainability of Growth in its Network Solutions Business and Fiscal 2027 Revenue Outlook
Robbins LLP has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased shares between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia misled investors about the sustainability of growth in its Network Solutions business and its fiscal year 2027 revenue outlook. This comes after Phreesia lowered its fiscal year 2027 revenue guidance due to weakening pharmaceutical marketing commitments and reduced visibility into future spending.
PHR (NYSE: PHR) affiliate files to sell 1,371 ESPP shares via Fidelity
An affiliate of Phreesia, Inc. (NYSE: PHR) has filed a Form 144 notice indicating their intent to sell 1,371 shares of common stock acquired through an ESPP purchase on June 30, 2026, with Fidelity Brokerage Services LLC facilitating the sale. The filing also discloses prior sales by Yvonne Hui in April and May 2026, totaling over 11,800 shares. This type of filing is for transparency regarding large share sales that may impact stock price.
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has announced that a class action lawsuit has been filed against Phreesia, Inc. (NYSE: PHR) and its officers. The lawsuit alleges that Phreesia made materially false and misleading statements about its demand, revenue streams, and marketing commitments between May 8, 2025, and March 30, 2026. Investors who suffered losses are encouraged to join the case, with a lead plaintiff deadline of July 13, 2026.
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia made false and misleading statements about slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors who suffered losses are encouraged to join the case, with a lead plaintiff deadline of July 13, 2026.
PHR Deadline: PHR Investors with Losses in Excess of $100K Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit
The Rosen Law Firm is reminding investors who purchased Phreesia, Inc. (NYSE: PHR) common stock between May 8, 2025, and March 30, 2026, and have losses exceeding $100,000, of the July 13, 2026 lead plaintiff deadline in a securities fraud lawsuit. The lawsuit alleges that Phreesia made false or misleading statements regarding slowing demand and reduced visibility in key revenue streams related to pharmaceutical marketing commitments. Investors are encouraged to contact the Rosen Law Firm for information on joining the class action.
PHR Investors Have Opportunity to Lead Phreesia, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today!
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and its officers, inviting investors to join. The lawsuit alleges that Phreesia made false and misleading statements about slowing demand and weakened pharmaceutical marketing commitments between May 8, 2025, and March 30, 2026. Investors who suffered losses have until July 13, 2026, to request to be appointed as lead plaintiff.
Deadline Alert: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP is reminding investors of Phreesia Inc. (PHR) who suffered losses to contact them regarding a securities fraud lawsuit. The lawsuit alleges that Phreesia made misleading statements about its long-term growth and minimized risks in its Network Solutions segment before a significant revenue growth projection decrease in March 2026. Investors who purchased shares between May 8, 2025, and March 30, 2026, have until July 13, 2026, to file as lead plaintiff.
PHR SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Phreesia, Inc. Stockholders Have Opportunity to Lead Class Action Lawsuit!
Bronstein, Gewirtz & Grossman, LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE:PHR) and its officers. The lawsuit alleges that Phreesia made false and misleading statements about slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing commitments between May 8, 2025, and March 30, 2026. Investors who purchased Phreesia securities during this period are encouraged to join the lawsuit, with a deadline to request lead plaintiff status by July 13, 2026.
Deadline Alert: Phreesia Inc. (PHR) Shareholders Who Lost
Glancy Prongay Wolke & Rotter LLP is urging shareholders of Phreesia Inc. (PHR) who experienced losses to contact them regarding a securities fraud lawsuit. The lawsuit stems from a significant drop in Phreesia's stock price after the company announced lowered revenue growth projections for fiscal 2027, which allegedly contradicted earlier positive statements. The deadline for investors to file a lead plaintiff motion in the class action is July 13, 2026.
Phreesia (PHR) accounting officer adds shares through 2019 ESPP
Phreesia, Inc.'s Principal Accounting Officer, Yvonne Hui, acquired 1,371 shares of common stock through the company’s 2019 Employee Stock Purchase Plan (ESPP). The shares were bought at $8.75 each for the period covering January 1, 2026, to June 30, 2026, and represent 85% of the June 30 closing price. Following this transaction, Hui directly holds 25,279 Phreesia shares.
Phreesia (NYSE: PHR) GC adds 1,265 shares through ESPP purchase
Phreesia, Inc.'s General Counsel and Secretary, Allison C. Hoffman, acquired 1,265 shares of common stock through the company's 2019 Employee Stock Purchase Plan (ESPP). The shares were bought at $8.75 each, representing 85% of the closing price on June 30, 2026, increasing her direct holdings to 158,574 shares. This transaction, filed as a Form 4, is noted as a plan-based purchase rather than an open-market trade.
Bragar Eagel & Squire, P.C. Reminds Phreesia, Inc. (PHR) Investors of the Upcoming July 13th Lead Plaintiff Deadline and Urges Investors to Contact the Firm
Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Phreesia, Inc. (PHR) for alleged federal securities law violations. The lawsuit claims Phreesia made false statements and failed to disclose slowing demand and reduced visibility in its Network Solutions segment, specifically due to weakened pharmaceutical marketing commitments. Investors who purchased Phreesia common stock between May 8, 2025, and March 30, 2026, have until July 13, 2026, to apply to be appointed as lead plaintiff.
Deadline Alert: Phreesia Inc. (PHR) Shareholders Who Lost
Glancy Prongay Wolke & Rotter LLP reminds investors of Phreesia Inc. (PHR) that the deadline to file as lead plaintiff in a class action lawsuit is July 13, 2026. The lawsuit alleges that Phreesia misrepresented its long-term growth outlook and minimized risks related to its Network Solutions segment's growth during the Class Period of May 8, 2025, to March 30, 2026. Investors suffered losses when the company announced significantly lowered revenue growth projections for fiscal 2027, causing its stock price to drop by 26.6%.
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is reminding investors of a class action lawsuit against Phreesia, Inc. (NYSE: PHR) for alleged securities fraud. Investors who purchased securities between May 8, 2025, and March 30, 2026, are encouraged to contact the firm before July 13, 2026, as the company allegedly made false and misleading statements regarding its growth outlook and pharmaceutical marketing commitments.
Phreesia Inc. (PHR) Shareholders Who Lost Money Have Opportunity to Lead Securities Fraud Lawsuit
The Law Offices of Frank R. Cruz announce a securities fraud class action lawsuit against Phreesia Inc. (PHR) for investors who suffered losses. The lawsuit alleges that Phreesia created a false impression of reliable long-term growth and minimized risks related to its Network Solutions segment between May 8, 2025, and March 30, 2026. Investors are encouraged to participate before the lead plaintiff deadline of July 13, 2026.
Bragar Eagel & Squire, P.C. Reminds Phreesia, Inc. (PHR) Investors of the Upcoming July 13th Lead Plaintiff Deadline and Urges Investors to Contact the Firm
Bragar Eagel & Squire, P.C. has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased common stock between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia and its executives made false and misleading statements regarding the company's slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. Investors have until July 13, 2026, to apply to be appointed as lead plaintiff.
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Phreesia, Inc. on behalf of investors who purchased securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia made false and misleading statements regarding slowing demand, diminished visibility into revenue streams, and weakened pharmaceutical marketing commitments for its Network Solutions segment. Investors who suffered losses are encouraged to join the class action, with a lead plaintiff deadline of July 13, 2026.
PHREESIA, INC. (PHR) INVESTIGATION ALERT: Bernstein Liebhard Announces Investigation of Phreesia, Inc.
Bernstein Liebhard LLP has announced an investigation into Phreesia, Inc. (NYSE: PHR) to determine if certain directors and officers breached their fiduciary duties. The firm is reaching out to shareholders who purchased shares before May 8, 2025, to discuss their legal rights and options. Bernstein Liebhard LLP is a nationally recognized investor rights law firm that has recovered over $3.5 billion for its clients since 1993.
Portnoy Law Firm Announces Class Action on Behalf of Phreesia, Inc. Investors
The Portnoy Law Firm has announced a class action lawsuit against Phreesia, Inc. on behalf of investors who purchased securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia failed to disclose weakening pharmaceutical marketing commitments and reduced visibility into future spending, leading to a lowered revenue outlook for fiscal year 2027. This news caused Phreesia's stock price to drop significantly by approximately 27%.
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is encouraging investors who purchased Phreesia, Inc. (NYSE: PHR) securities between May 8, 2025, and March 30, 2026, to join a class action lawsuit. The lawsuit alleges that Phreesia made false and misleading statements regarding its long-term growth outlook and confidence in fiscal year 2027 projections, particularly concerning its Network Solutions segment and pharmaceutical marketing commitments. Investors who suffered losses are urged to contact the firm before July 13, 2026, to discuss their rights.
Phreesia, Inc.(NYSE: PHR) added to Russell 3000E Value Benchmark
Phreesia, Inc. (NYSE: PHR) has been added to the Russell 3000E Value Benchmark. This news highlights recent market activities for Phreesia, including various downgrades from analyst firms and its Q1 2027 earnings report. The article also provides a company profile, financial data, and analyst consensus information for Phreesia.
Phreesia, Inc.(NYSE: PHR) added to Russell 3000 Value Benchmark
Phreesia, Inc. (NYSE: PHR) has been added to the Russell 3000 Value Benchmark. This update follows several recent analyst rating changes and financial reports for the company, including downgrades from Piper Sandler, Wells Fargo, and Barclays. Phreesia provides software solutions for healthcare organizations, focusing on patient access, registration, payments, and clinical assessments.
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) for alleged securities fraud, urging investors who bought shares between May 8, 2025, and March 30, 2026, to come forward by July 13, 2026. The lawsuit claims Phreesia made misleading statements about its long-term growth and fiscal year 2027 projections, particularly regarding pharmaceutical marketing commitments as a growth driver for its Network Solutions segment. Investors who suffered losses due to these alleged misrepresentations are encouraged to contact the firm.
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman, LLC has filed a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia made false and misleading statements about slowing demand, diminished revenue visibility, and weakened pharmaceutical marketing commitments in its Network Solutions segment. Investors who suffered losses have until July 13, 2026, to request to be appointed lead plaintiff.
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) and its officers, alleging violations of federal securities laws. The lawsuit claims that Phreesia made false and misleading statements about its financial health and revenue streams between May 8, 2025, and March 30, 2026. Investors who purchased Phreesia securities during this period are encouraged to join the case, with a lead plaintiff deadline of July 13, 2026.
PHREESIA DEADLINE: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Phreesia, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - PHR
The Rosen Law Firm is reminding investors of Phreesia, Inc. (NYSE: PHR) who purchased common stock between May 8, 2025, and March 30, 2026, about the July 13, 2026, lead plaintiff deadline in a securities class action lawsuit. The lawsuit alleges that Phreesia made misleading statements regarding slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. Investors who suffered damages are encouraged to contact the firm to join the class action.
Phreesia, Inc. Actuals & Estimates (DUS:19P)
This article provides financial actuals and analyst estimates for Phreesia, Inc. (DUS:19P), including income statement, balance sheet, and cash flow data. It details key financial figures such as earnings per share, revenue, and net income, alongside analyst price targets and historical stock performance. The article also confirms the company's employee count, EBITDA, and upcoming earnings date.
Phreesia (PHR) director Gillian Munson receives 19,290 RSU equity award
Phreesia, Inc. director Gillian Munson was granted 19,290 Restricted Stock Units (RSUs) valued at $9.59 per unit as part of her board compensation. These RSUs will vest in full by June 24, 2027, or the next annual shareholder meeting, and Munson has elected to defer their receipt until after leaving the board or five years from the grant date. Following this award, her direct holdings in Phreesia common stock now total 66,104 shares.
Deadline Alert: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP is reminding investors of Phreesia Inc. (NYSE: PHR) who suffered losses to contact the firm regarding a securities fraud lawsuit. The lawsuit alleges that Phreesia made misleading statements about its long-term growth and its Network Solutions segment's revenue until the company announced significantly lowered revenue growth projections for fiscal 2027 on March 30, 2026, causing a substantial drop in stock price. Investors who purchased shares between May 8, 2025, and March 30, 2026, have until July 13, 2026, to move for lead plaintiff.
Phreesia (PHR) director Ramin Sayar awarded 19,290 RSUs of common stock
Phreesia director Ramin Sayar was granted 19,290 Restricted Stock Units (RSUs) of common stock, valued at $9.59 per share, under the company's 2019 Stock Option and Incentive Plan. These RSUs will vest fully on the earlier of June 24, 2027, or the next annual stockholder meeting. Following this grant, Sayar's direct holdings in Phreesia total 52,725 shares.
Phreesia director Egbuonu-Davis sells $24,263 in common stock By Investing.com
Phreesia director Lisa Egbuonu-Davis sold 2,546 shares of common stock worth $24,263 on June 25, 2026, following the acquisition of 19,290 restricted stock units (RSUs) on June 24, 2026. Despite a 46% stock decline, InvestingPro metrics suggest the stock is undervalued with a "GREAT" financial health score, and analysts have recently increased their earnings outlook. This transaction, made under a Rule 10b5-1 plan, places her direct holdings at 38,316 shares after the sales and RSU grant.
Phreesia (PHR) director Mark D. Smith awarded 19,290 RSUs with deferred settlement
Phreesia director Mark Douglas Smith was granted 19,290 Restricted Stock Units (RSUs) of common stock, valued at $9.59 per unit. These RSUs will vest on the earlier of June 24, 2027, or the next annual stockholder meeting. Smith has chosen to defer the settlement of these RSUs, meaning he will receive the shares after leaving the board or in five years, whichever comes first, bringing his total direct holdings to 56,643 shares.
Deadline Alert: Phreesia Inc. (PHR) Shareholders Who Lost Money Urged To Contact Glancy Prongay Wolke & Rotter LLP About Securities Fraud Lawsuit
Glancy Prongay Wolke & Rotter LLP reminds investors of Phreesia Inc. (NYSE: PHR) who suffered losses to consider filing a lead plaintiff motion by July 13, 2026. This class action lawsuit alleges that Phreesia misled investors about its long-term growth outlook and minimized risks from slowing growth in its Network Solutions segment, leading to a significant stock price drop on March 31, 2026, after lowered revenue projections were announced.
PHR Deadline Alert: The Gross Law Firm Reminds Phreesia,
The Gross Law Firm is alerting investors of Phreesia, Inc. (NYSE: PHR) about a securities class action lawsuit with a lead plaintiff deadline of July 13, 2026. The lawsuit alleges that Phreesia made misleading statements regarding its slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. This led to a significant stock price decline after the company announced reduced revenue growth projections for fiscal year 2027.
PHREESIA, INC. (PHR) INVESTIGATION ALERT: Bernstein Liebhard Announces Investigation of Phreesia, Inc.
Bernstein Liebhard LLP has launched an investigation into Phreesia, Inc. (NYSE: PHR) to determine if its directors and officers breached their fiduciary duties. The investigation focuses on shareholders who purchased shares before May 8, 2025. The firm is inviting affected investors to discuss their legal rights and options.
Class Action Lawsuit Filed: Phreesia, Inc. (PHR) - Join by July 13, 2026 - Contact Levi & Korsinsky
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia made misleading statements about slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. After the company announced significantly reduced revenue growth projections on March 30, 2026, its stock price dropped by approximately 27%.
Phreesia, Inc. Actuals & Estimates (NYSE:PHR)
This article provides financial actuals and estimates for Phreesia, Inc. (NYSE:PHR), including its current stock price, market capitalization, and analyst forecasts. It details the company's historical performance, recent earnings, revenue, and future earnings and revenue expectations, along with other key financial metrics like EBITDA and employee count. The article also addresses frequently asked questions about investing in PHR stock.
Phreesia, Inc. Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your Rights - PHR
The DJS Law Group has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) for alleged securities law violations. The lawsuit claims that Phreesia made misleading statements regarding its pharmaceutical marketing commitments and revenue guidance. Shareholders who purchased PHR shares between May 8, 2025, and March 30, 2026, are encouraged to contact the firm to discuss their rights, with a lead plaintiff deadline of July 13, 2026.
PHR Investors Have Opportunity to Lead Phreesia, Inc. Securities Fraud Lawsuit with the Schall Law Firm
The Schall Law Firm is encouraging investors of Phreesia, Inc. (NYSE: PHR) to join a class action lawsuit alleging securities fraud. The lawsuit claims Phreesia made false and misleading statements regarding its long-term growth outlook and fiscal year 2027 projections, specifically concerning pharmaceutical marketing commitments in its Network Solutions segment. Investors who purchased securities between May 8, 2025, and March 30, 2026, are urged to contact the firm before the July 13, 2026 deadline.
Investors in Phreesia, Inc. (PHR): Protect Your Rights - Contact Levi & Korsinsky Before July 13, 2026
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Phreesia, Inc. (NYSE:PHR) on behalf of investors who purchased securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia made false and misleading statements regarding its slowing demand and reduced visibility in key revenue streams, specifically weakened pharmaceutical marketing commitments. This alleged misconduct led to a significant drop in stock price following an announcement of reduced revenue growth projections for fiscal year 2027.
Phreesia (NYSE: PHR) investors approve directors, KPMG and executive pay
Phreesia, Inc. (NYSE: PHR) stockholders held their annual meeting on June 24, 2026, approving the election of Chaim Indig and Jon Kessler as Class I directors for three-year terms. They also ratified KPMG LLP as the independent registered public accounting firm for the fiscal year ending January 31, 2027, and approved the compensation of the company’s named executive officers on a non-binding advisory basis. The various proposals received strong support from the votes cast by shareholders.
Bronstein, Gewirtz & Grossman LLC Urges Phreesia, Inc. Investors to Act: Class Action Filed Alleging Investor Harm
Bronstein, Gewirtz & Grossman LLC has filed a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia made false and misleading statements about slowing demand and weakened pharmaceutical marketing commitments, which impacted its business prospects. Investors who suffered losses are encouraged to join the case, with a lead plaintiff deadline of July 13, 2026.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 13, 2026 in Phreesia, Inc. Lawsuit - PHR
The Gross Law Firm is notifying shareholders of Phreesia, Inc. (NYSE: PHR) about a lead plaintiff deadline of July 13, 2026, in a class action lawsuit. The lawsuit alleges that Phreesia made false and misleading statements regarding its demand and revenue streams, particularly weakened pharmaceutical marketing commitments, leading to a significant stock price decline. Shareholders who purchased PHR shares between May 8, 2025, and March 30, 2026, are encouraged to register to participate.
Levi & Korsinsky Notifies Phreesia, Inc. (PHR) Shareholders of Class Action Lawsuit and July 13, 2026 Deadline
Levi & Korsinsky, LLP has announced a securities class action lawsuit against Phreesia, Inc. (NYSE:PHR) on behalf of investors who suffered losses due to alleged securities fraud between May 8, 2025, and March 30, 2026. The lawsuit claims Phreesia made misleading statements regarding demand and revenue visibility, particularly concerning its Network Solutions segment's pharmaceutical marketing commitments. Following an announcement on March 30, 2026, of significantly reduced revenue growth projections for fiscal year 2027, Phreesia's stock price declined by approximately 27%.
Phreesia, Inc. Class Action Reminder - Robbins LLP Encourages PHR Investors to Contact the Firm for Information About Their Rights
Robbins LLP has filed a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased common stock between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia misled investors regarding the sustainability of growth in its Network Solutions business and its fiscal year 2027 revenue outlook. The company's stock price significantly dropped after it lowered its revenue outlook, citing reduced visibility and lower spending commitments from pharmaceutical manufacturers.
Phreesia, Inc. Class Action Reminder - Robbins LLP Encourages PHR Investors to Contact the Firm for Information About Their Rights
Robbins LLP is reminding investors of a class action lawsuit filed against Phreesia, Inc. (NYSE: PHR) for alleged misleading statements made between May 8, 2025, and March 30, 2026. The lawsuit claims Phreesia failed to disclose weakening pharmaceutical marketing commitments, reduced visibility into future spending, and lower-than-anticipated commitments from Network Solutions clients, which put their fiscal year 2027 revenue guidance at risk. Shareholders who purchased stock during this period are encouraged to contact Robbins LLP by July 13, 2026, to learn about their rights.
Portnoy Law Firm Announces Class Action on Behalf of Phreesia, Inc. Investors
The Portnoy Law Firm has announced a class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who purchased securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia failed to disclose weakening pharmaceutical marketing commitments, reduced visibility into future spending, lower client spending, and increased variability in Network Solutions revenue forecasting, which put its fiscal year 2027 revenue guidance at risk. This allegedly led to a significant 27% drop in Phreesia's stock price following the company's lowered revenue outlook announcement on March 30, 2026.
Lost Money on Phreesia, Inc. (PHR)? Urged to Join Class Action Before July 13, 2026 - Contact Levi & Korsinsky
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Phreesia, Inc. (NYSE: PHR) on behalf of investors who suffered losses due to alleged securities fraud between May 8, 2025, and March 30, 2026. The lawsuit claims Phreesia made misleading statements concerning slowing demand and reduced visibility in key revenue streams, particularly in its Network Solutions segment. Following an announcement of significantly reduced revenue growth projections for fiscal year 2027, Phreesia's stock price declined by approximately 27%.
The Gross Law Firm Reminds Shareholders of a Lead Plaintiff Deadline of July 13, 2026 in Phreesia, Inc. Lawsuit - PHR
The Gross Law Firm is reminding shareholders of Phreesia, Inc. (NYSE: PHR) about a lead plaintiff deadline of July 13, 2026, in a class action lawsuit. The lawsuit alleges that Phreesia made misleading statements about its demand and revenue streams, particularly regarding pharmaceutical marketing commitments, leading to a significant drop in stock price after reduced revenue projections were announced. Shareholders are encouraged to contact the firm to learn more about participating in the class action.
Levi & Korsinsky Urges Phreesia, Inc. (PHR) Shareholders to Act Before Lead Plaintiff Deadline July 13, 2026
Levi & Korsinsky, LLP has filed a securities class action lawsuit against Phreesia, Inc. (NYSE:PHR) on behalf of investors who purchased securities between May 8, 2025, and March 30, 2026. The lawsuit alleges that Phreesia made misleading statements regarding its demand and revenue streams, particularly in its Network Solutions segment, leading to a significant stock price decline. Shareholders have until July 13, 2026, to act as lead plaintiff.
